Isocorydine suppresses doxorubicin-induced epithelial-mesenchymal transition via inhibition of ERK signaling pathways in hepatocellular carcinoma.

Pan, Jie-Xue; Chen, Gang; Li, Jun-Jian; Zhu, Qian-Dong; Li, Jing-Jie; Chen, Zong-Jing; Yu, Zheng-Ping; Ye, Long-Yun

Pan, Jie-Xue; Chen, Gang; Li, Jun-Jian; Zhu, Qian-Dong; Li, Jing-Jie; Chen, Zong-Jing; Yu, Zheng-Ping; Ye, Long-Yun.

Affiliation

Pan JX; The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Chen G; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Li JJ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Zhu QD; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Li JJ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Chen ZJ; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Yu ZP; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.
Ye LY; Department of Hepatobiliary Surgery, The First Affiliated Hospital of Wenzhou Medical UniversityWenzhou, China.

Am J Cancer Res ; 8(1): 154-164, 2018.

Article de En | MEDLINE | ID: mdl-29416928

Mots clés

Doxorubicin; EMT; HCC; Isocorydine

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Am J Cancer Res Année: 2018 Type de document: Article Pays d'affiliation: Chine Pays de publication: États-Unis d'Amérique

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google